Print preview VALIDITY EXPIRED This page was not yet approved. Publications |
2008
manual entry, 2009. III. 19. |
Tárkányi I, Aradi J.:: Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease,, Biochimie 90, 156-72., pp. 156-172 type of document: Journal paper/Review paper impact factor: 2.899 language: English
|
2006
manual entry, 2009. III. 17. |
Pendino F, Tarkanyi I, Dudognon C, Hillion J, Lanotte M, Aradi J, Segal-Bendirdjian E.: Telomeres and telomerase: pharmacological targets for new anticancer strategies, Curr Cancer Drug Targets, 6, 147-180, pp. 147-180 type of document: Journal paper/Review paper impact factor: 5.677 number of independent citations: 18 language: English
|
2006
manual entry, 2009. III. 17. |
Kemény-Beke Á, Aradi J, Damjanovich J, Beck Z, Facskó A, Berta A, Bodnár A.: Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine, Cancer Lett. 237, 67-75, pp. 67-75 type of document: Journal paper/Review paper impact factor: 3.277 number of independent citations: 12 language: English
|
2006
manual entry, 2009. III. 17. |
Wu Y, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong J, Chen GQ, Ségal-Bendirdjian E.: Immunodetection of human telomerase transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths, J Cell Sci. 119, 2797-806., pp. 2797-2806 type of document: Journal paper/Review paper impact factor: 6.430 number of independent citations: 19 language: English
|
2005
manual entry, 2013. XI. 03. |
Horváth A, Tőkés S, Hartman T, Watson K, Turpin JA, Buckheit RW Jr, Sebestyén Z, Szöllősi J, Benkő I, Bardos TJ, Dunn JA, Fésüs L, Tóth FD, Aradi J.: Potent inhibition of HIV-1 entry by (s4dU)35., Virology. 334, 214-23, pp. 214-223 type of document: Journal paper/Article number of independent citations: 4 language: English
|
2005
manual entry, |
Tarkanyi I, Horváth A, Szatmari I, Eizert H, Vámosi G, Damjanovich S, Ségal-Bendirdjian E, Aradi J.: Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide, FEBS Lett. 579, 1411-16. type of document: Journal paper impact factor: 3.420 number of independent citations: 8
|
2001
manual entry, |
Szatmari I, Aradi J.: Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme., Nucleic Acids Res. 29, E3. type of document: Journal paper impact factor: 6.370 number of independent citations: 16
|
2000
manual entry, |
Szatmari I, Tőkés S, Dunn CB, Bardos TJ, Aradi J.: Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis., Anal Biochem. 282, 80-8. type of document: Journal paper impact factor: 1.980 number of independent citations: 13
|
1992
manual entry, |
Balajthy Z, Aradi J, Kiss IT, Elődi P.: Synthesis and functional evaluation of a peptide derivative of 1-beta-D-arabinofuranosylcytosine., J. Med. Chem. 35, 3344-3349. type of document: Journal paper impact factor: 3.800 number of independent citations: 8
|
1966
manual entry, |
Tőkés S, Aradi J.: (s4dU)35: a novel, highly potent oligonucleotides inhibitor of the human immunodeficiency virus type-1 reverse transcriptase, FEBS Lett. 396, 43-46. type of document: Journal paper impact factor: 3.750 number of independent citations: 2
|
| Number of independent citations to these publications: | 100 |
|
|